DNA Machines - Company finances
|
EUR
|
2024
From: 2024-09-18
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 25,464 | 111,272 |
| Profit before tax | 8,815 | 10,150 |
| Net profit | 8,049 | 9,642 |
| Equity | 9,049 | 18,691 |
| Liabilities | 1,531 | 46,407 |
| Non-current assets | 0 | 0 |
| Current assets | 10,580 | 65,098 |
| Total assets | 10,580 | 65,098 |
|
Taxes paid
|
||
| STI taxes | - | 1,266 |
|
Financial indicators
|
||
| Revenue change y/y | - | +337.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 76.1% | 14.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 88.9% | 51.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 31.6% | 8.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 34.6% | 9.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 2.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 111,272 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
DNA Machines - Social security debts
The amount of overdue SODRA debt for the company DNA Machines as of the last working day is: 3 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-14 | 3.12 |
| 2026-08-23 | 2026-08-23 | 106.35 |
| 2026-08-19 | 2026-08-19 | 106.35 |
| 2026-07-19 | 2026-07-23 | 212.70 |
| 2026-07-16 | 2026-07-17 | 212.70 |
| 2026-06-16 | 2026-07-15 | 106.35 |
| 2026-05-17 | 2026-05-25 | 212.70 |
| 2026-05-03 | 2026-05-14 | 106.35 |
| 2026-04-20 | 2026-04-29 | 106.35 |
| 2026-03-27 | 2026-03-27 | 106.35 |
| 2026-03-17 | 2026-03-25 | 106.35 |
| 2026-02-18 | 2026-02-25 | 214.11 |
| 2026-02-09 | 2026-02-17 | 107.76 |
| 2026-01-21 | 2026-02-08 | 1.41 |
| 2025-11-18 | 2025-12-14 | 106.35 |
| 2025-10-16 | 2025-11-06 | 106.35 |
DNA Machines - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-27 | 2026-06-05 | 0.94 |
| 2026-03-20 | 2026-03-26 | 1.88 |
| 2026-01-31 | 2026-03-19 | 0.94 |
| 2025-12-09 | 2025-12-15 | 0.66 |
| 2025-12-05 | 2025-12-08 | 0.69 |
| 2025-11-07 | 2025-11-07 | 100.0 |
| 2025-08-27 | 2025-08-28 | 14.45 |
| 2025-08-25 | 2025-08-26 | 780.05 |
| 2025-08-24 | 2025-08-24 | 775.45 |
| 2025-08-22 | 2025-08-23 | 766.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
DNA Machines, UAB (code 306993202) is a Private Limited Liability Company engaged in diagnostic imaging services and medical laboratory activities. In 2025, the latest financial year, the company generated revenue of €111.3K and net profit of €9.6K, with a profit margin of 8.7%. Revenue grew strongly year on year by 337.0%, reflecting a clear expansion from the 2024 period, when revenue was €25.5K over 104 days and net profit was €8.0K. Profit also increased in absolute terms, although margin declined as the business scaled. The balance sheet strengthened materially during 2025: total assets rose to €65.1K from €10.6K a year earlier, equity increased to €18.7K, and liabilities reached €46.4K. The company’s debt-to-equity ratio stood at 2.48, while asset turnover was 1.71x, indicating active use of its asset base. Revenue per employee was €111.3K, and profit per employee was €9.6K. Overall, the 2025 results show rapid growth, continued profitability, and a more leveraged capital structure.